Momordica charantia (Bitter melon)

Alternative Medicine Review

Volumn 12, Issue 4, 2007, Pages 360-363

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CHARANTIA; CHARANTIN; CUCURBUTANOID; GLUCOSE; GUANYLATE CYCLASE; HEMOGLOBIN A1C; MOMORDICA CHARANTIA EXTRACT; MOMORDICIN; OLEANOLIC ACID; P INSULIN; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CLINICAL TRIAL; DRUG MECHANISM; DRUG RESEARCH; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MOMORDICA CHARANTIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTON NUCLEAR MAGNETIC RESONANCE;

BACTERIAL INFECTIONS; DIABETES MELLITUS; DYSLIPIDEMIAS; HUMANS; MOMORDICA CHARANTIA; PHYTOTHERAPY; PLANT EXTRACTS; VIRUS DISEASES;

EID: 37549043582     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. National Bitter Melon Council. http://www. bittermelon.org/pages/learn/ about_reference.html [Accessed July 3, 2007]
2. Tropical Plant Database, Raintree Nutrition. http://rain-tree.com/ bitmelon.htm. [Accessed July 3, 2007]
3. Bitter melon - Wikipedia, the free encyclopedia. http://wikipedia.org/ wiki/Bitter_melon. [Accessed July 2, 2007]
4. Oishi Y, Sakamoto T, Udagawa H, et al. Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction. Biosci Biotechnol Biochem 2007;71:735-740.
5. Chaturvedi P, George S, Milinganyo M, Tripathi YB. Effect of Momordica charantia on lipid profile and oral glucose tolerance in diabetic rats. Phytother Res 2004;18:954-956.
6. Ahmed I, Lakhani MS, Gillett M, et al. Hypotriglyceridemic and hypocholesterolemic effects of anti-diabetic Momordica charantia (karela) fruit extract in streptozotocin-induced diabetic rats. Diabetes Res Clin Pract 2001;51:155-161.
7. Harinantenaina L, Tanaka M, Takaoka S, et al. Momordica charantia constituents and antidiabetic screening of the isolated major compounds. Chem Pharm Bull (Tokyo) 2006;54:1017-1021.
8. Cunnick J, Takemoto D. Bitter melon (Momordica charantia). J Naturopath Med 1993;4:16-21.
9. Sarkar S, Pranava M, Marita R. Demonstration of the hypoglycemic action of Momordica charantia in a validated animal model of diabetes. Pharmacol Res 1996;33:1-4.
10. Shibib BA, Khan LA, Rahman R. Hypoglycemic activity of Coccinia indica and Momordica charantia in diabetic rats: depression of the hepatic gluconeogenic enzymes glucose-6-phosphatase and fructose-1,6 bisphosphatase and elevation of both liver and red-cell shunt enzyme glucose-6-phosphate dehydrogenase. Biochem J 1993;292:267-270.
11. Yibchok-Anun S, Adisakwattana S, Yao CY, et al. Slow acting protein extract from fruit pulp of Momordica charantia with insulin secretagogue and insulinomimetic activities. Biol Pharm Bull 2006;29:1126-1131.
12. Welihinda J, Arvidson G, Gylfe E, et al. The insulin-releasing activity of the tropical plant Momordica charantia. Acta Biol Med Ger 1982;41:1229-1240.
13. Ahmed I, Adeghate E, Sharma AK, et al. Effects of Momordica charantia fruit juice on islet morphology in the pancreas of the streptozotocin-diabetic rat. Diabetes Res Clin Pract 1998;40:145-151.
14. Vesely DL, Graves WR, Lo TM, et al. Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata). Biochem Biophys Res Commun 1977;77:1294-1299.
15. Claflin AJ, Vesely DL, Hudson JL, et al. Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata). Proc Natl Acad Sci U S A 1978;75:989-993.
16. Manabe M, Takenaka R, Nakasa T, Okinaka O. Induction of anti-inflammatory responses by dietary Momordica charantia L. (bitter gourd). Biosci Biotechnol Biochem 2003;67:2512-2517.
17. Baldwa VS, Bhandari CM, Pangaria A, Goyal RK. Clinical trial in patients with diabetes mellitus of an insulin-like compound obtained from plant sources. Upsala J Med Sci 1977;82:39-41.
18. Welihinda J, Karunanayake EH, Sheriff MH, Jayasinghe KS. Effect of Momordica charantia on the glucose tolerance in maturity onset diabetes. J Ethnopharmacol 1986;17:277-282.
19. Srivastava Y, Venkatakrishna-Bhatt H, Verma Y, et al. Antidiabetic and adaptogenic properties of Momordica charantia extract. An experimental and clinical evaluation. Phytother Res 1993;7:285-289.
20. Dans AM, Villarruz, MV, Jimeno CA, et al. The effect of Momordica charantia capsule preparation on glycemic control in type 2 diabetes mellitus needs further studies. J Clin Epidemiol 2007;60:554-559.
21. Chaturvedi P. Role of Momordica charantia in maintaining the normal levels of lipids and glucose in diabetic rats fed a high-fat and low-carbohydrate diet. Br J Biomed Sci 2005;62:124-126.
22. Chen Q, Li ET. Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines. Br J Nutr 2005;93:747-754.
23. Senanayake GV, Maruyama M, Sakono M, et al. The effects of bitter melon (Momordica charantia) extracts on serum and liver lipid parameters in hamsters fed cholesterol-free and cholesterol-enriched diets. J Nutr Sci Vitaminol (Tokyo) 2004;50:253-257.
24. Jiratchariyakul W, Wiwat C, Vongsakul M, et al. HIV inhibitor from Thai bitter gourd. Planta Med 2001;67:350-353.
25. Bourinbaiar AS, Lee-Huang S. The activity of plant-derived antiretroviral proteins MAP30 and GAP31 against Herpes simplex virus in vitro. Biochem Biophys Res Commun 1996;219:923-929.
26. Zhang QC. Preliminary report on the use of Momordica charantia extract by HIV patients. J Naturopath Med 1992;3:65-69.
27. Omoregbe RE, Ikuebe OM, Ihimire IG. Antimicrobial activity of some medicinal plants extracts on Escherichia coli, Salmonella paratyphi and Shigella dysenteriae. Afr J Med Med Sci 1996;25:373-375.
28. Khan MR, Omoloso AD. Momordica charantia and Allium sativum: broad spectrum antibacterial activity. Korean J Pharmacog 1998;29:155-158.
29. Yasui Y, Hosokawa M, Sahara T, et al. Bitter gourd seed fatty acid rich in 9c,11t,13t-conjugated linolenic acid induces apoptosis and up-regulates the GADD45, p53 and PPARgamma in human colon cancer Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids 2005;73:113-119.
30. Lee-Huang S, Huang PL, Sun Y, et al. Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30. Anticancer Res 2000;20:653-659.
31. Chan WY, Tam PP, Yeung HW. The termination of early pregnancy in the mouse by beta-momorcharin. Contraception 1984;29:91-100.
32. Head KA. Herbal remedies that may help control blood sugar. In: Bratman S, Kroll D, eds. The Natural Pharmacist, Everything You Need to Know About Diabetes. New York, NY: Prima Publications, Inc.; 1999:51-53.
33. Brinker FJ. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications; 1998.